AQST · CIK 0001398733 · operating
Aquestive Therapeutics, Inc. (AQST) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $514 million, Aquestive Therapeutics, Inc. is a small-cap company. The stock currently trades at $4.21, up 5.25% today, with a 52-week range of $2.12–$7.55.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.51 | $-0.51 | -292.3% | |
| 2023 | $-0.13 | $-0.13 | +88.4% | |
| 2022 | $-1.12 | $-1.12 | +39.5% | |
| 2021 | $-1.85 | $-1.85 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-05 | 0001628280-25-010506 | SEC ↗ |
| 2023-12-31 | 2024-03-05 | 0001628280-24-009010 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001628280-23-010180 | SEC ↗ |
| 2021-12-31 | 2022-03-08 | 0001628280-22-005393 | SEC ↗ |
| 2020-12-31 | 2021-03-09 | 0001140361-21-007811 | SEC ↗ |
| 2019-12-31 | 2020-03-11 | 0001140361-20-005499 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001140361-19-004934 | SEC ↗ |